We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HAFC:NASDAQHanmi Financial Corporation Analysis

Data as of 2026-06-13 - not real-time

$31.75

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Hanmi Financial (HAFC) is trading at $31.75, comfortably above its 20‑day SMA of 30.28 and the 50‑day SMA of 29.47, confirming a bullish price bias. Momentum indicators are supportive: the RSI sits at 65.9 (approaching overbought but still under the 70 threshold) and the MACD line (0.50) remains above its signal (0.39) with a positive histogram, signaling continued upward pressure. The stock’s beta of 0.80 indicates lower volatility than the market, yet recent 30‑day volatility of roughly 25% suggests price swings remain sizable. Fundamentals reinforce the technical picture: a trailing PE of 11.8 versus an industry average of 16.8 points to relative cheapness, while a dividend yield of 3.5% and a modest payout ratio (40.7%) underline cash‑flow strength.
The balance sheet shows ample liquidity with cash of $256 M against debt of $171 M, and operating margins above 44% demonstrate efficient earnings generation. Revenue growth of 14.6% and forward EPS growth to $3.42 suggest a solid growth trajectory, positioning HAFC as a blend of value and growth attributes. However, decreasing volume trends and a proximity to the resistance level of $31.87 temper expectations, implying that near‑term upside may be limited while the longer‑term valuation case remains attractive.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technicals (SMA crossover, MACD bullish)
  • Proximity to resistance at $31.87
  • Decreasing volume indicating potential short‑term consolidation

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued PE relative to industry peers
  • Strong dividend yield with sustainable payout
  • Robust operating margins and revenue growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Solid balance sheet with ample cash and low leverage
  • Consistent earnings generation and forward EPS upside
  • Low beta and defensive banking sector exposure

Key Metrics & Analysis

Financial Health

Revenue Growth14.60%
Profit Margin30.62%
P/E Ratio11.8
ROE10.42%
ROA1.04%
P/B Ratio1.2
Op. Cash Flow$203.5M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI65.8
Support$28.80
Resistance$31.87
MA 20$30.28
MA 50$29.47
MA 200$27.28
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$119.23
Target Price$32.88
Upside/Downside3.54%
GradeUndervalued
TypeBlend
Dividend Yield3.53%

Risk Assessment

Beta0.80
Volatility25.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.